Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: Genotypes, virulence factors and antifungal susceptibility testing

Journal of Medical Microbiology

Volumn 61, Issue PART12, 2012, Pages 1750-1757

  Sun, Wei ^a   Su, Jianrong ^a   Xu, Shuzhen ^a   Yan, Donghui ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; FORMAZAN; HEMOLYSIN; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; PHOSPHOLIPASE; POLYSTYRENE; PROTEINASE; VORICONAZOLE;

AGED; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOFILM; CLINICAL ARTICLE; FEMALE; FUNGAL VIRULENCE; GENOTYPE; HEMOLYSIS; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MALE; NONHUMAN; PRIORITY JOURNAL; TRICHOSPORON ASAHII; URINARY TRACT INFECTION;

AGED; AGED, 80 AND OVER; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CROSS INFECTION; DNA, FUNGAL; DNA, INTERGENIC; DRUG RESISTANCE, MULTIPLE, FUNGAL; FEMALE; FLUCYTOSINE; GENETIC VARIATION; GENOTYPE; HEMOLYSIN PROTEINS; HUMANS; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; PEPTIDE HYDROLASES; PHOSPHOLIPASES; PYRIMIDINES; TRIAZOLES; TRICHOSPORON; TRICHOSPORONOSIS; URINARY TRACT INFECTIONS; VIRULENCE FACTORS;

EID: 84869486626     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.049817-0     Document Type: Article

References (43)

1. Ahmad, S., Khan, Z., Mokaddas, E. & Khan, Z. U. (2004). Isolation and molecular identification of Candida dubliniensis from nonhuman immunodeficiency virus-infected patients in Kuwait. J Med Microbiol 53, 633-637.
2. Bayramoglu, G., Sonmez, M., Tosun, I., Aydin, K. & Aydin, F. (2008). Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin. Infection 36, 68-70.
3. Chagas-Neto, T. C., Chaves, G. M., Melo, A. S. & Colombo, A. L. (2009). Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. J Clin Microbiol 47, 1074-1081.
4. Colombo, A. L., Padovan, A. C. & Chaves, G. M. (2011). Current knowledge of Trichosporon spp. and trichosporonosis. Clin Microbiol Rev 24, 682-700.
5. Dagdeviren, M., Cerikcioglu, N. & Karavus, M. (2005). Acid proteinase, phospholipase and adherence properties of Candida parapsilosis strains isolated from clinical specimens of hospitalised patients. Mycoses 48, 321-326.
6. Di Bonaventura, G., Pompilio, A., Picciani, C., Iezzi, M., D'Antonio, D. & Piccolomini, R. (2006). Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. Antimicrob Agents Chemother 50, 3269-3276.
7. Fera, M. T., La Camera, E. & De Sarro, A. (2009). New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance. Expert Rev Anti Infect Ther 7, 981-998.
8. Frank, D. N., Wilson, S. S., St Amand, A. L. & Pace, N. R. (2009). Culture-independent microbiological analysis of Foley urinary catheter biofilms. PLoS ONE 4, e7811.
9. Furlaneto-Maia, L., Specian, A. F., Bizerra, F. C., de Oliveira, M. T. & Furlaneto, M. C. (2008). In vitro evaluation of putative virulence attributes of oral isolates of Candida spp. obtained from elderly healthy individuals. Mycopathologia 166, 209-217.
10. Girmenia, C., Pagano, L., Martino, B., D'Antonio, D., Fanci, R., Specchia, G., Melillo, L., Buelli, M., Pizzarelli, G. & other authors (2005). Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol 43, 1818-1828.
11. Guo, L. N., Xiao, M., Kong, F., Chen, S. C., Wang, H., Sorrell, T. C., Jiang, W., Dou, H. T., Li, R. Y. & Xu, Y. C. (2011). Three-locus identification, genotyping, and antifungal susceptibilities of medically important Trichosporon species from China. J Clin Microbiol 49, 3805-3811.
12. Hawser, S. P., Norris, H., Jessup, C. J. & Ghannoum, M. A. (1998). Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol 36, 1450-1452.
13. Kalkanci, A., Sugita, T., Arikan, S., Yucesoy, M., Ener, B., Otag, F., Kiraz, N., Kustimur, S., Sancak, B. & other authors (2010). Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients. Med Mycol 48, 141-146.
14. Kauffman, C. A., Vazquez, J. A., Sobel, J. D., Gallis, H. A., McKinsey, D. S., Karchmer, A. W., Sugar, A. M., Sharkey, P. K., Wise, G. J. & other authors (2000). Prospective multicenter surveillance study of funguria in hospitalized patients. Clin Infect Dis 30, 14-18.
15. Krzossok, S., Birck, R., Henke, S., Hof, H., van der Woude, F. J. & Braun, C. (2004). Trichosporon asahii infection of a dialysis PTFE arteriovenous graft. Clin Nephrol 62, 66-68.
16. Kumar, S., Bandyopadhyay, M., Mondal, S. & Pal, N. (2011). A rare case of nosocomial urinary tract infection due to Trichosporon asahii. J Glob Infect Dis 3, 309-310.
17. Lundstrom, T. & Sobel, J. (2001). Nosocomial candiduria: a review. Clin Infect Dis 32, 1602-1607.
18. Luo, G., Samaranayake, L. P. & Yau, J. Y. (2001). Candida species exhibit differential in vitro hemolytic activities. J Clin Microbiol 39, 2971-2974.
19. Makimura, K., Murayama, S. Y. & Yamaguchi, H. (1994). Detection of a wide range of medically important fungi by the polymerase chain reaction. J Med Microbiol 40, 358-364.
20. Martinez-Lacasa, J., Maña, J., Niubó, R., Rufi, G., Saez, A. & Fernández-Nogué s, F. (1991). Long-term survival of a patient with prosthetic valve endocarditis due to Trichosporon beigelii. Eur J Clin Microbiol Infect Dis 10, 756-758.
21. Marty, F. M., Barouch, D. H., Coakley, E. P. & Baden, L. R. (2003). Disseminated trichosporonosis caused by Trichosporon loubieri. J Clin Microbiol 41, 5317-5320.
22. Mekha, N., Sugita, T., Ikeda, R., Nishikawa, A., Autthateinchai, R., Poonwan, N. & Sawanpanyalert, P. (2010). Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients. Mycopathologia 169, 67-70.
23. Mirza, S. H. (1993). Disseminated Trichosporon beigelii infection causing skin lesions in a renal transplant patient. J Infect 27, 67-70.
24. Mooty, M. Y., Kanj, S. S., Obeid, M. Y., Hassan, G. Y. & Araj, G. F. (2001). A case of Trichosporon beigelii endocarditis. Eur J Clin Microbiol Infect Dis 20, 139-142.
25. Moretti-Branchini, M. L., Fukushima, K., Schreiber, A. Z., Nishimura, K., Papaiordanou, P. M., Trabasso, P., Tanaka, R. & Miyaji, M. (2001). Trichosporon species infection in bone marrow transplanted patients. Diagn Microbiol Infect Dis 39, 161-164.
26. CLSI (2009). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Informational Supplement. M27-A3. Wayne, PA: Clinical and Laboratory Standards Institute.
27. Negri, M., Martins, M., Henriques, M., Svidzinski, T. I., Azeredo, J. & Oliveira, R. (2010). Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients. Mycopathologia 169, 175-182.
28. Padhye, A. A., Hall, L. & Roberts, G. D. (2002). Deep-seated trichosporonosis in an immunocompetent patient: a case report of uterine trichosporonosis-correction. Clin Infect Dis 35, 108-109, author reply 109.
29. Pini, G., Faggi, E., Donato, R. & Fanci, R. (2005). Isolation of Trichosporon in a hematology ward. Mycoses 48, 45-49.
30. Price, M. F., Wilkinson, I. D. & Gentry, L. O. (1982). Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia 20, 7-14.
31. Rastogi, V. L. & Nirwan, P. S. (2007). Invasive trichosporonosis due to Trichosporon asahii in a non-immunocompromised host: a rare case report. Indian J Med Microbiol 25, 59-61.
32. Richards, M. J., Edwards, J. R., Culver, D. H. & Gaynes, R. P. (2000). Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 21, 510-515.
33. Rodriguez-Tudela, J. L., Diaz-Guerra, T. M., Mellado, E., Cano, V., Tapia, C., Perkins, A., Gomez-Lopez, A., Rodero, L. & Cuenca-Estrella, M. (2005). Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother 49, 4026-4034.
34. Rodriguez-Tudela, J. L., Gomez-Lopez, A., Alastruey-Izquierdo, A., Mellado, E., Bernal-Martinez, L. & Cuenca-Estrella, M. (2007). Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1. Diagn Microbiol Infect Dis 58, 435-440.
35. Sabharwal, E. R. (2010). Successful management of Trichosporon asahii urinary tract infection with fluconazole in a diabetic patient. Indian J Pathol Microbiol 53, 387-388.
36. Shin, J. H., Kee, S. J., Shin, M. G., Kim, S. H., Shin, D. H., Lee, S. K., Suh, S. P. & Ryang, D. W. (2002). Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 40, 1244-1248.
37. Sood, S., Pathak, D., Sharma, R. & Rishi, S. (2006). Urinary tract infection by Trichosporon asahii. Indian J Med Microbiol 24, 294-296.
38. Sugita, T., Ichikawa, T., Matsukura, M., Sueda, M., Takashima, M., Ikeda, R., Nishikawa, A. & Shinoda, T. (2001). Genetic diversity and biochemical characteristics of Trichosporon asahii isolated from clinical specimens, houses of patients with summer-type-hypersens-itivity pneumonitis, and environmental materials. J Clin Microbiol 39, 2405-2411.
39. Sugita, T., Nakajima, M., Ikeda, R., Matsushima, T. & Shinoda, T. (2002). Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species. J Clin Microbiol 40, 1826-1830.
40. Walsh, T. J., Groll, A., Hiemenz, J., Fleming, R., Roilides, E. & Anaissie, E. (2004). Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 10 (Suppl. 1), 48-66.
41. Wolf, D. G., Falk, R., Hacham, M., Theelen, B., Boekhout, T., Scorzetti, G., Shapiro, M., Block, C., Salkin, I. F. & Polacheck, I. (2001). Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units. J Clin Microbiol 39, 4420-4425.
42. Xia, Z., Yang, R., Wang, W. & Cong, L. (2012). Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients. Mycopathologia 173, 127-133.
43. Yun, S. J., Lee, J. B., Shin, M. G., Kim, S. J., Won, Y. H. & Lee, S. C. (2006). Cutaneous abscess by Trichosporon asahii developing on a steroid injection site in a healthy adult. Clin Exp Dermatol 31, 545-547.